[1]
J. D. Albrecht, “Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects”, Acta Derm Venereol, vol. 102, p. adv00722, May 2022.